{
  "FMP_API_KEY": "1vvmyNvtw1H3jFeOwInCLZ2dkc2SpSwQ",
  "ANTHROPIC_API_KEY": "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",
  "OPENAI_API_KEY": "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",
  "email_address": "daquinn@targetedequityconsulting.com",
  "password": "fhbsgzgicuenpcdv",
  "imap_server": "imap.gmail.com",
  "target_senders": [
    "reply@email.investors.com",
    "pharma@endpointsnews.com",
    "info@kedm.com",
    "thebarronsdaily@barrons.com",
    "newsletter@biopharmcatalyst.com",
    "yourweekendreading@substack.com",
    "Newsletter@io-fund.com",
    "Premium@io-fund.com",
    "davelutz@bloomberg.net",
    "contact@stockanalysis.com"
  ],
  "output_dir": ".",
  "send_email": true,
  "email_recipient": "daquinn@targetedequityconsulting.com",
  "smtp_server": "smtp.gmail.com",
  "smtp_port": 587,
  "logo_path": "C:\\Users\\daqui\\PycharmProjects\\PythonProject1\\company_logo.png",
  "use_ai_summary": true,
  "ai_provider": "openai"
}